February 28, 2019

Yesterday, the Montana State Senate approved SB 71, a bill that would regulate pharmacy benefit managers (PBMs) and lower prescription drug costs by requiring rebates to go to insurance companies and that those insurance companies use those rebates to lower drug prices...

February 27, 2019

Yesterday, on February 26th, the Senate Finance Committee held a second hearing on rising prescription drug costs. During the three hour hearing, Senators attacked the drug company executives for their immoral and anticompetitive business practices, told moving stories...

February 21, 2019

Last fall’s meeting between the Department of Justice and several State Attorneys General reminds us that sound antitrust enforcement is not just a federal affair.  While the Department of Justice called the meeting to discuss the antitrust concerns regarding the conso...

February 20, 2019

Ohio Attorney General Dave Yost announced he is seeking the repayment of almost $16 million paid to the pharmacy benefit manager (PBM) OptumRx, after the company overcharged the state government for drugs.

Yost said that he will take the PBM to nonbinding mediation, as...

February 15, 2019

President Trump's proposed replacement for the North American Free Trade Agreement (NAFTA) would give drug companies ten years' protection from cheaper competition for biologic drugs, a step that would harm efforts to promote drug competition and lower drug prices.

Last...

February 15, 2019

On Wednesday, the Department of Justice filed a response to objections to the merger of the health insurance company Aetna and CVS, the pharmacy benefit manager (PBM) and pharmacy retailer. Consumer advocates, doctors and hospitals, pharmacists, and others wrote to DOJ...

February 13, 2019

Yesterday, on February 12th, the House Ways and Means Committee held its first hearing on the rising costs of prescription drug prices and how to reduce them. During a lively three and a half hour meeting, representatives asked tough questions about pharmaceutical comp...

February 12, 2019

Optum Rx, one of America's largest pharmacy benefit managers (PBMs) sent a letter to drug companies outlining several demands the companies must meet if they seek to lower list prices for their medicines. This would put another obstacles in the path of lowering drug pr...